- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
The Effect of Human Atrial Natriuretic Polypeptide (hANP) on Pulmonary Circulation
-
- Nagashima Kenshi
- Second Department of Internal Medicine, Gifu University School of Medicine
-
- Gotoh Kohshi
- Second Department of Internal Medicine, Gifu University School of Medicine
-
- Yagi Yasuo
- Second Department of Internal Medicine, Gifu University School of Medicine
-
- Terashima Yasushi
- Second Department of Internal Medicine, Gifu University School of Medicine
-
- Fujiwara Hisayoshi
- Second Department of Internal Medicine, Gifu University School of Medicine
Bibliographic Information
- Other Title
-
- ヒト肺循環系に対するヒト心房性ナトリウム利尿ペプチドの効果
Search this article
Description
<p>To evaluate the effect of human atrial natriuretic peptide (hANP)to pulmonary circulation, we calculated pulmonary artery compliance (Cpa) and pulmonary venous compliance (Cpv), using radionuclide angiocardiography and Swan-Ganz catheter. Cpa was calculated by Reuben’s equation using pulmonary arterial pressure records and pulmonary capillary wedge pressure (Ppcw). The pulmonary blood volume was measured with our own method, using radionuclide angiocardiography. Then, the pulmonary venous volume was measured by dividing pulmonary arterial volume from pulmonary blood volume. Cpv was calculated with pulmonary venous volume and Ppcw. Synthetic a—human atrial natriuretic polypeptide was infused in 22 patients with various heart disease. The infusion of hANP at rate of 0.1 μg/kg/min significantly decreased pulmonary arterial pressure, pulmonary capillary wedge pressure and right atrial pressure. The hANP infusion significantly increased cardiac output. The hANP infusion significantly decreased total systemic resistance and total pulmonary resistance. Although Cpa was not significantly changed, Cpv was increased significantly by the hANP infusion. The results suggest that human arterial natriuretic peptide have potent vasorelaxant effects in the pulmonary venous system.</p>
Journal
-
- The Japanese Journal of Phlebology
-
The Japanese Journal of Phlebology 12 (2), 111-117, 2001
Japanese Society of Phlebology
- Tweet
Details 詳細情報について
-
- CRID
- 1390573870507948032
-
- ISSN
- 21865523
- 09157395
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- OpenAIRE
-
- Abstract License Flag
- Disallowed